Director: Irving M. Reti, MBBS
Long known for its effectiveness, especially in the treatment of medication-resistant depression, electroconvulsive therapy (ECT) is one of the most applied and tested treatment methods for many psychiatric illnesses. Common symptoms of depression may include feelings of sadness, lack of pleasure in activities, changes in appetite or sleep, concentration difficulties, hopelessness, and thoughts of suicide. Patients are typically referred when medications are not providing sufficient relief or if side-effects are intolerable. We treat hundreds of patients a year with ECT here at Johns Hopkins.
New brain stimulating technologies have emerged in recent years that can directly regulate brain function without producing the cognitive side-effects associated with ECT and which do not require anesthesia. Transcranial magnetic stimulation (rTMS) is one of these technologies that has proven effective in clinical trials and we now offer both conventional and deep TMS for the treatment of major depression.
The field of brain stimulation continues to evolve as technology improves and as we learn more about brain function and how these treatment methods affect it. Our research program includes clinical trials utilizing ECT and TMS as well as laboratory investigations into how they work and how they can be improved.
LocationThe Brain Stimulation Program
The Johns Hopkins Hospital
600 N. Wolfe Street
Baltimore, MD 21287
For outpatient rTMS or ECT questions
Michael Tibbs, Program Coordinator
For inpatient ECT admission
Mary Mesick, Admissions Coordinator